Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Fevertree (FEVR) Share Price

Price 829.50p on 28-07-2026 at 11:29:39
Change 10.00p 1.22%
Buy 834.00p
Sell 830.00p
Last Trade: Sell 601.00 at 831.7776p
Day's Volume: 343,614
Last Close: 819.50p
Open: 825.50p
ISIN: GB00BRJ9BJ26
Day's Range 822.00p - 839.00p
52wk Range: 711.00p - 973.00p
Market Capitalisation: £933.47m
VWAP: 827.04581p
Shares in Issue: 112.53m

Fevertree (FEVR) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Sell* 601 831.7776p Ordinary
12:29:38 - 28-Jul-26
Sell* 287 830.00p SI Trade
12:28:43 - 28-Jul-26
Buy* 122 829.50p Automatic Execution
12:24:54 - 28-Jul-26
Buy* 109 829.00p Automatic Execution
12:24:54 - 28-Jul-26
Buy* 125 829.00p Automatic Execution
12:24:54 - 28-Jul-26
Buy* 1 829.00p SI Trade
12:24:43 - 28-Jul-26
Buy* 1,300 827.526p SI Trade
12:17:40 - 28-Jul-26
Sell* 301 827.3467p Ordinary
12:16:32 - 28-Jul-26
Buy* 51 827.00p Automatic Execution
12:12:01 - 28-Jul-26
Sell* 49 826.50p Automatic Execution
12:11:59 - 28-Jul-26
See more Fevertree trades

Fevertree (FEVR) Share Price History

Time period:
to
Date Open High Low Close Volume
27th Jul 2026 (Mon) 812.50 830.50 812.50 819.50 184,376
24th Jul 2026 (Fri) 829.00 836.00 813.00 820.00 161,137
23rd Jul 2026 (Thu) 850.00 864.00 829.00 829.00 546,020
22nd Jul 2026 (Wed) 850.00 865.00 849.00 850.00 365,617
21st Jul 2026 (Tue) 820.00 858.00 812.00 853.50 840,251
20th Jul 2026 (Mon) 810.00 818.50 803.00 815.00 392,284
17th Jul 2026 (Fri) 806.00 825.00 806.00 812.50 244,776
16th Jul 2026 (Thu) 800.00 814.00 792.00 814.00 284,809
15th Jul 2026 (Wed) 785.00 800.00 776.00 798.50 281,963
14th Jul 2026 (Tue) 774.00 795.00 761.00 788.00 994,376
13th Jul 2026 (Mon) 780.00 783.00 767.00 774.00 243,366
10th Jul 2026 (Fri) 780.00 780.00 766.00 777.50 521,212
9th Jul 2026 (Thu) 750.00 766.50 745.00 766.00 485,531
8th Jul 2026 (Wed) 792.00 800.00 758.50 766.00 456,465
7th Jul 2026 (Tue) 819.00 819.00 779.00 788.50 764,690
6th Jul 2026 (Mon) 804.50 804.50 781.00 781.00 239,984
3rd Jul 2026 (Fri) 814.00 814.00 799.00 800.00 167,152
2nd Jul 2026 (Thu) 819.50 822.00 806.00 806.00 343,484
1st Jul 2026 (Wed) 815.50 821.50 799.50 817.50 291,983
30th Jun 2026 (Tue) 780.00 817.00 780.00 812.50 823,128
29th Jun 2026 (Mon) 780.00 823.00 780.00 810.00 1,484,296
See more Fevertree price history

Fevertree (FEVR) Regulatory News

Date Source Headline
21st Jul 2026 7:00 am RNS Transaction in Own Shares
15th Jul 2026 7:00 am RNS Block Listing Return
14th Jul 2026 7:00 am RNS Transaction in Own Shares
7th Jul 2026 7:00 am RNS Transaction in Own Shares
1st Jul 2026 10:20 am RNS Total Voting Rights
1st Jul 2026 7:00 am RNS Update on share buyback extension
30th Jun 2026 9:42 am RNS Board Change
30th Jun 2026 7:00 am RNS Transaction in Own Shares
23rd Jun 2026 7:00 am RNS Transaction in Own Shares
16th Jun 2026 7:00 am RNS Transaction in Own Shares
See more Fevertree regulatory news

Fevertree (FEVR) Share News

IN BRIEF: Fevertree Drinks starts GBP30 million buyback extension

1st Jul 2026 13:52

Fevertree Drinks PLC - London-based maker of premium drink mixers - Fevertree starts the GBP30 million extension of its share buyback programme, which it had announced at its annual general meeting last month. The new GBP30 million buyback follows a buyback of the same size completed earlier in the year. It begins on Wednesday and will be completed by December 31. It will be run by Investec Bank PLC. Read More

UK dividends calendar - next 7 days

19th Jun 2026 12:11

Read More

Fevertree Drinks extends share buyback after solid start to year

9th Jun 2026 11:26

(Alliance News) - Fevertree Drinks PLC on Tuesday announced a GBP30 million extension to its share buyback programme and said it remains confident of achieving full-year market expectations. Read More

LONDON BRIEFING: GSK agrees to buy US cancer drug maker Nuvalent

9th Jun 2026 07:58

(Alliance News) - GSK agrees to buy US cancer treatment firm Nuvalent for USD10.6 billion, AstraZeneca advances its own weight-loss treatment while Bellway reports an "increasingly challenging" housing market. Read More

UK shareholder meetings calendar - next 7 days

2nd Jun 2026 13:44

Read More

See more Fevertree news
FTSE 100 Latest
Value10,829.16
Change47.41

Login to your account

Forgot Password?

Not Registered